Human Genome Sciences, Inc. (HGSI) Misses Q2 EPS by 1c
Tweet
Share
E-mailGet Alerts HGSI Hot Sheet
Price: $14.24 --0%
Financial Fact:
Research and development collaborative agreements: 280K
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Research and development collaborative agreements: 280K
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Human Genome Sciences, Inc. (NASDAQ: HGSI) reported Q2 EPS of ($0.42), $0.01 worse than the analyst estimate of ($0.41). Revenue for the quarter came in at $24.9 million versus the consensus estimate of $29.03 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
- Ross Stores (ROST) Tops Q2 EPS by 72c, Beats on Revenue
- Nordson Corp. (NDSN) Tops Q3 EPS by 16c; Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
